MedTrace Logo

Durability and Safety of CCH With Two Different Injection Techniques in Cellulite With Laxity

NCT05249257 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 20

Last updated 2023-01-19

No results posted yet for this study

Summary

All participants who completed the EN3835-224 study will be invited to participate in this observational study to evaluate long term durability of response and safety.

Conditions

  • Cellulite
  • Laxity; Skin
  • Edematous Fibrosclerotic Panniculopathy

Sponsors & Collaborators

  • Endo Pharmaceuticals

    lead INDUSTRY

Principal Investigators

  • Karen Chajko · Endo Pharmaceuticals

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-01-25
Primary Completion
2022-09-12
Completion
2022-09-12

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05249257 on ClinicalTrials.gov